HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $782,939 | -21.0% | 14,953 | -38.6% | 0.11% | -12.7% |
| Q1 2024 | $990,477 | -50.4% | 24,348 | -55.0% | 0.13% | -67.6% |
| Q4 2023 | $1,998,834 | -11.7% | 54,081 | -8.7% | 0.39% | -40.7% |
| Q3 2023 | $2,263,121 | +30.4% | 59,244 | +23.2% | 0.66% | +22.4% |
| Q2 2023 | $1,735,183 | +353.8% | 48,106 | +380.5% | 0.54% | +315.5% |
| Q1 2023 | $382,358 | -68.9% | 10,012 | -53.7% | 0.13% | -73.9% |
| Q4 2022 | $1,231,088 | +24.9% | 21,636 | -13.2% | 0.50% | +19.3% |
| Q3 2022 | $986,000 | – | 24,936 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |